CPT 83068: Screen for Unstable (Thermolabile) Hemoglobin

CPT code 83068 is a laboratory screening assay for unstable (thermolabile) hemoglobin variants in whole blood. This assay detects hemoglobin forms that denature with heat and are frequently linked to hemolytic anemia or neonatal jaundice, making it clinically relevant for diagnosing causes of unexplained hemolysis and guiding further confirmatory testing.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and payment policies for 83068 influence access to diagnostic evaluation of hemoglobinopathies and hemolytic disorders across inpatient and outpatient laboratory settings.

Readers will learn the clinical context and intended use of CPT code 83068, the typical sites where the service is performed, and which major payers are considered in national coverage discussions. The publication provides benchmarks and policy-oriented information relevant to laboratory directors, billing professionals, and clinical teams engaged in hemoglobinopathy diagnosis. Where specific payer policy details, taxonomies, ICD-10 pairings, or related codes are not provided in the input, the report indicates that those data are not available.

Billing Code Overview

CPT code 83068 describes a laboratory screening test to detect and approximate unstable (thermolabile) hemoglobin in whole blood. The procedure identifies hemoglobin variants that are prone to denaturation and often associated with hemolysis or jaundice.

Service type: Laboratory diagnostic assay

Typical site of service: Clinical laboratory or hospital laboratory, with specimen collection from whole blood

Data not available in the input.

Clinical Context

A 6-year-old child presents to the pediatric clinic with a history of intermittent jaundice, dark urine, and recent fatigue after a febrile illness. The clinician suspects a hemolytic process and orders laboratory testing including a screen for unstable (thermolabile) hemoglobin to evaluate for hemoglobin variants that denature with heat and are associated with hemolysis. A whole blood specimen is collected at the outpatient phlebotomy station and sent to the clinical laboratory. The lab analyst performs 83068 (unstable/thermolabile hemoglobin screen) using a heat-denaturation or equivalent assay, documents findings in the laboratory information system, and reports abnormal results to the ordering provider. If the screen is positive or atypical, follow-up testing such as hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), or genetic testing is ordered. Typical sites of service include outpatient clinics, hospital inpatient wards when hemolysis is suspected, and hospital-based clinical laboratories. The service type is a laboratory diagnostic screen performed on a whole blood specimen as part of an evaluation for hemolytic anemia, neonatal jaundice, or suspected unstable hemoglobinopathies.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional component of a split technical/professional lab service, if applicable.

Taxonomy Code	Specialty	Notes
207Q00000X	Hematology	Hematologists interpret hemoglobinopathy screening and follow-up testing.
207RH0000X	Pathology	Pathologists and clinical laboratory directors oversee test performance and validation.
208000000X	Pediatric Medicine	Pediatricians frequently order this test for neonatal jaundice or pediatric hemolytic presentations.
207L00000X	Clinical Laboratory	Clinical laboratory scientists/medical technologists perform the assay and document results.
207LP2900X	Hematopathology	Hematopathologists provide diagnostic correlation and guidance for follow-up testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D55.0`	Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	G6PD deficiency is a common cause of unstable hemoglobin-related hemolysis and may prompt screening for unstable hemoglobin variants.
`D59.0`	Autoimmune hemolytic anemia	Hemolysis evaluation often includes unstable hemoglobin screening to exclude hemoglobin instability as a cause.
`D57.1`	Sickle-cell disease without crisis	Hemoglobinopathy patients may undergo additional screening or confirmatory testing for unstable variants.
`D59.9`	Hemolytic anemia, unspecified	General hemolysis diagnosis warranting a workup that includes `83068`.
`P59.9`	Neonatal jaundice, unspecified	Newborns with significant jaundice may be screened for unstable hemoglobin contributing to hemolysis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`85025`	Blood count; automated differential WBC count	Often ordered concurrently to evaluate anemia and reticulocyte response when hemolysis is suspected.
`82043`	Bilirubin; total	Commonly performed to quantify jaundice severity in hemolytic processes.
`83020`	Hemoglobin; glycosylated (A1C)	Not directly related; excluded from this table.
`83050`	Hemoglobin electrophoresis, qualitative or quantitative	Follow-up diagnostic test to characterize hemoglobin variants when `83068` screening is positive.
`83021`	Hemoglobin; other unspecified	Not standard; excluded.
`86140`	Antibody identification panel	May be ordered if immune-mediated hemolysis is suspected (complements the hemolysis workup).
`88267`	Cytogenetic analysis; chromosome rearrangement, fish	Not typically related; excluded.

OpenPayer

Summary & Overview